# Puma Biotechnology, Inc.: Form 8-K, filed May 2, 2024

- Company: [Puma Biotechnology, Inc.](/companies/pbyi.md) (CIK 1401667)
- Form: 8-K
- Filed: 2024-05-02
- Accepted by EDGAR: May 2, 2024, 16:18 ET
- Period: 2024-05-02
- Accession: 0001437749-24-014382
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401667/000143774924014382/pbyi20240430_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401667/000143774924014382/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401667/000143774924014382/pbyi20240430_8k.htm

Filed May 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-014382. Last ingested by Listed: Nov 5, 2026, 17:46 ET. No prices; not investment advice.